Human Pharmaceutical Portfolio

Nintib 100 mg Capsule

Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.

Molecule / StrengthNintedanib 100 mg
ManufacturerCipla Ltd
CategoryLung Disease
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.